Overview

Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity

Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This is a comparison of metformin versus placebo in NASH patients receiving bariatric surgery for obesity.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital, Ghent
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Metformin